- 专利标题： INSULIN CONTAINING PHARMACEUTICAL COMPOSITIONS
-
申请号： US16280603申请日： 2019-02-20
-
公开(公告)号： US20190183979A1公开(公告)日： 2019-06-20
- 发明人: Mathias Norrman , Susanne Hostrup , Dorte Bjerre Steensgaard , Holger Martin Strauss , Rosa Rebecca Erritzoee Hansen , Svend Havelund , Morten Schlein , Jesper Soendergaard Pedersen
- 申请人： Novo Nordisk A/S
- 优先权： EP16204688.2 20161216
- 主分类号： A61K38/28
- IPC分类号： A61K38/28 ; A61K47/02 ; A61K47/10 ; A61P5/48
摘要：
The present invention is in the field of pharmaceutical compositions for the treatment of medical conditions relating to diabetes. More specifically the invention provides pharmaceutical compositions comprising a long-acting acylated derivative of a human insulin analogue, and to the medical use of such compositions for basal insulin administration therapy.
公开/授权文献
- US10596231B2 Insulin containing pharmaceutical compositions 公开/授权日：2020-03-24
信息查询
IPC分类:
